Dr. David E. Ross is a Midlothian, Virginia based psychiatrist who is specialized in Psychiatry. His current practice location is 2621 Promenade Pkwy, Midlothian. Patients can reach him at 804-594-7046 or can fax him at 804-594-2635. Dr. David E. Ross is M.D. in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1942237060. Dr. David E. Ross specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
Dr. David E. Ross speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1942237060
NPI Enumeration Date:
26 Jun, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. David E. Ross 2621 Promenade Pkwy, Midlothian, Virginia
Zip:
23113-1431
Phone Number:
804-594-7046
Fax Number:
804-594-2635
Patients can reach Dr. David E. Ross at 2621 Promenade Pkwy, Midlothian, Virginia or can call to book an appointment on 804-594-7046.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.